tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Value
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Smart Value
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Optimistic Buy Rating for Oncolytics Biotech Driven by Promising Clinical Developments and Strategic Plans
RatingsOptimistic Buy Rating for Oncolytics Biotech Driven by Promising Clinical Developments and Strategic Plans
15d ago
ONCY
Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating
PremiumRatings
Oncolytics Biotech’s Promising Advancements and Strategic Developments Drive Buy Rating
22d ago
ONCY
Oncolytics price target lowered to C$5 from C$6 at RBC Capital
PremiumThe Fly
Oncolytics price target lowered to C$5 from C$6 at RBC Capital
22d ago
ONCY
Oncolytics price target lowered to $3 from $5 at Maxim
PremiumThe Fly
Oncolytics price target lowered to $3 from $5 at Maxim
22d ago
ONCY
Oncolytics Biotech’s Financial Stability at Risk: Urgent Need for New Financing
PremiumCompany Announcements
Oncolytics Biotech’s Financial Stability at Risk: Urgent Need for New Financing
24d ago
ONCY
Oncolytics Biotech Advances Cancer Trials with Promising Results
PremiumCompany AnnouncementsOncolytics Biotech Advances Cancer Trials with Promising Results
25d ago
ONCY
Oncolytics Biotech’s Earnings Call: Clinical Progress Amid Challenges
Premium
Company Announcements
Oncolytics Biotech’s Earnings Call: Clinical Progress Amid Challenges
25d ago
ONCY
Oncolytics reports Q4 EPS (10c) vs. (5c) last year
Premium
The Fly
Oncolytics reports Q4 EPS (10c) vs. (5c) last year
25d ago
ONCY
Oncolytics Biotech (ONCY) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Oncolytics Biotech (ONCY) Q4 Earnings Cheat Sheet
28d ago
ONCY
Oncolytics Biotech to Discuss 2024 Financial Results and Operational Highlights
PremiumCompany Announcements
Oncolytics Biotech to Discuss 2024 Financial Results and Operational Highlights
1M ago
6K
ONCY
Oncolytics Biotech Advances Cancer Trials, Strengthening 2025 Pipeline
PremiumCompany Announcements
Oncolytics Biotech Advances Cancer Trials, Strengthening 2025 Pipeline
1M ago
ONCY
Oncolytics Biotech advances pancreatic, anal cancer trials
PremiumThe Fly
Oncolytics Biotech advances pancreatic, anal cancer trials
1M ago
ONCY
Oncolytics provides progress update for pelareorep in pancreatic and anal cancer
PremiumThe FlyOncolytics provides progress update for pelareorep in pancreatic and anal cancer
1M ago
ONCY
Oncolytics Biotech Advances Cancer Treatment Pipeline with Key 2025 Developments
Premium
Company Announcements
Oncolytics Biotech Advances Cancer Treatment Pipeline with Key 2025 Developments
1M ago
ONCY
Oncolytics making progress in 2025 with regulatory, clinical advancements
Premium
The Fly
Oncolytics making progress in 2025 with regulatory, clinical advancements
1M ago
ONCY
Oncolytics Biotech Receives Nasdaq Notification for Bid Price Deficiency
PremiumCompany Announcements
Oncolytics Biotech Receives Nasdaq Notification for Bid Price Deficiency
2M ago
ONCY
Oncolytics receives noncompliance notification from Nasdaq
PremiumThe Fly
Oncolytics receives noncompliance notification from Nasdaq
2M ago
ONCY
Oncolytics Biotech Announces Leadership Change Amid CEO Departure
PremiumCompany Announcements
Oncolytics Biotech Announces Leadership Change Amid CEO Departure
2M ago
6K
ONCY
Oncolytics Biotech Announces Leadership Change Amid CEO’s Health Concerns
PremiumCompany Announcements
Oncolytics Biotech Announces Leadership Change Amid CEO’s Health Concerns
2M ago
ONCY
Oncolytics Biotech Presents Promising Cancer Treatment Data
PremiumCompany AnnouncementsOncolytics Biotech Presents Promising Cancer Treatment Data
2M ago
6K
ONCY
Oncolytics Biotech Advances Pancreatic Cancer Treatment with Regulatory Approval
Premium
Company Announcements
Oncolytics Biotech Advances Pancreatic Cancer Treatment with Regulatory Approval
3M ago
ONCY
Oncolytics: PEI approves continuation of enrollment in Cohort 5 of GOBLET study
Premium
The Fly
Oncolytics: PEI approves continuation of enrollment in Cohort 5 of GOBLET study
3M ago
ONCY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >